Structure-based drug design - an Informa conference.
Brewerton
Suzanne
S
Astex Therapeutics Ltd, 436 Cambridge Science Park, Milton Road, Cambridge, CB4 0QA, UK. s.brewerton@astex-therapeutics.com
D051017:Apoptosis Regulatory Proteins / Q000235:genetics / Q000502:physiology; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D010770:Phosphotransferases / Q000037:antagonists & inhibitors; D043562:Receptors, G-Protein-Coupled / Q000235:genetics / Q000502:physiology; D013329:Structure-Activity Relationship
D051017:Apoptosis Regulatory Proteins; D004791:Enzyme Inhibitors; D043562:Receptors, G-Protein-Coupled; D010770:Phosphotransferases